Meningococcal Vaccines Industry Analysis: Projected to Soar at 8.6% CAGR, Hitting US$ 7.7 Billion by 2032 | FMI

Meningococcal Vaccines Industry

The global market for Meningococcal Vaccines is poised for significant growth, according to a recent report by Future Market Insights (FMI). Over the forecast period, the market is anticipated to expand at a robust Compound Annual Growth Rate (CAGR) of 8.6%, ultimately reaching US$3.4 billion in 2022.

The report highlights that the conjugate vaccines segment played a pivotal role in the market in 2021, capturing a substantial 62.6% revenue share. This segment’s strong performance reflects the growing demand for effective meningococcal vaccines across the globe.

FMI’s findings indicate a promising trajectory for the global meningococcal vaccines market, with a CAGR of 8.6% driving its remarkable growth. This significant increase is attributed to various factors, including rising awareness of meningococcal diseases and the importance of immunization, coupled with the continuous efforts of pharmaceutical companies to develop innovative and efficient vaccines.

Request a Sample Copy of This Report Now.
https://www.futuremarketinsights.com/reports/sample/REP-GB-1252

A classic example of how private-public partnerships are helping boost vaccination programmes across deep regional pockets is Brazil.

In 2010, Ezequiel Dias Foundation, Brazil formed a strategic alliance with Novartis Vaccines & Diagnostics for the sustainable supply of Menjugate MenC vaccines for Brazil’s National Immunization Program. By 2015, Brazil became self-sufficient in the production of the meningococcal C conjugated vaccine for the country’s public vaccination programmes. Such initiatives at the global level are anticipated to support global immunisation goals and at the same time boost growth of the meningococcal vaccines market.

Key Companies Profiled:

  • Sanofi Pasteur Inc.
  • GlaxoSmithKline Plc
  • Wyeth Pharmaceuticals
  • Bio-Manguinhos
  • Bio-Med Pvt. Limited
  • Chongqing Zhifei Biological Products Co., Ltd.
  • Hualan Biological Engineering Inc.
  • Incepta Pharmaceuticals Ltd.
  • Pfizer INC
  • Serum Institute of India Pvt. Ltd
  • Walvax Biotechnology Co., Ltd.

Factors Leading to Worldwide Adoption of Meningococcal Vaccination Programmes

The global meningococcal vaccines market is expected to be driven by enhanced access to vaccines in low and middle-income countries, growing investments by manufacturers and governments to cope with pandemic meningitis outbreaks, and rapidly growing consumption of meningococcal vaccines bolstered by immunisation alliances and mass vaccination campaigns among others.

Partnerships and alliances between manufacturers and governmental healthcare organisations are facilitating the speedy introduction of vaccines in some of the economically challenged countries of the Middle East and Africa region. Enhanced access to vaccines in under-penetrated global markets is expected to accelerate revenue growth of the global meningococcal vaccines market.

Approval of new vaccines in the U.S and Europe in 2015 and 2017 to treat meningococcal meningitis has revolutionised the global immunisation landscape. This is further boosting the growth trajectory of the global market for meningococcal vaccines.

GlaxoSmithKline to Lead the Global Meningococcal Vaccines Market with About 50% Market Share Recorded in 2017

The global meningococcal vaccines market is highly consolidated, with GlaxoSmithKline and Sanofi together holding about 80% of the global market share in 2017. Pfizer is the third largest company in this market with just under 12% market share in 2017.

Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/1252

Companies are expanding their production capacities through the acquisition of established vaccines production units of other global or local companies.

Sanofi has a huge pipeline of 17 active meningococcal vaccines programmes and is targeting emerging markets; while GlaxoSmithKline has 5 active pipeline programmes for meningococcal vaccines, all of which are in the phase II clinical stage. Addition of the vaccine Bexsero has enabled GlaxoSmithKline to defend its brand against Sanofi’s aggressive portfolio in the paediatric vaccines space.

Why Future Market Insights?

  • Comprehensive analysis on evolving purchase pattern across different geographies
    Detailed insights of market segments and sub-segments for historical as well as forecast period
    • A competitive analysis of prominent players and emerging players in the keyword market
    • Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Key Market Segments Covered in Meningococcal Vaccines Industry Research

By Product:

  • Polysaccharide
  • Conjugate

By Age Group:

  • Infants
  • Children
  • Adolescents & young Adults
  • Adults

By Distribution Channel:

  • Pharmacies
  • Community Clinics
  • Public Health Agencies
  • Others (hospital pharmacy, private market etc.)

 Author

Sabyasachi Ghosh (Associate Vice President at Future Industry Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Industry Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Industry Insights (FMI)

Future Industry Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the Industry. FMI stands as the leading global provider of Industry intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals Industrys. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Industry Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futureIndustryinsights.com
Website: https://www.futureIndustryinsights.com
LinkedInTwitterBlogs | YouTube

About the Author

Nikhil Kaitwade

Associate Vice President at Future Market Insights, Inc. has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.
His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.
Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these